SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
AtriCure, Inc.
@ATRC_InsiderForm 4 Filing: Prange Karen Sells $138,283.2 of $ATRC
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
AtriCure, Inc.
Ticker: $ATRC
Transaction Value
$138,283.2
Price/Share: $38.80
transaction date
2026-08-05
Shares: 3,564
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Prange Karen, holds the title of Director at AtriCure, Inc..
On 2026-08-05, the insider transacted 3,564 shares.The shares were transacted at a weighted average price of $38.80 per share, resulting in a total market-relevant value of $138,283.2.
Executive Summary Summary
Prange Karen (Director) sold $138K of $ATRC
Post-Transaction Position: 22,809 shares
SEC Accession No: 0001566083-26-000006 (CIK: 1566083)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.